Skip to main content
. 2020 Jun 17;86(11):2256–2265. doi: 10.1111/bcp.14328

FIGURE 2.

FIGURE 2

Trend in amoxicillin‐induced crystal nephropathy (AICN) notification to the French National Pharmacovigilance Database (FNPD) and marketing authorization holders pharmacovigilance databases (MAHPD). Black bar: amoxicillin; white bar: amoxicillin–clavulanate